RevBio is a Biotech company based in Lowell, MA. It has raised $45M in total funding. Latest round: Series A.
RevBio funding overview
RevBio is a Biotech company based in Lowell, MA. RevBio has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2024. The round record for RevBio runs through 2024; nothing later has been disclosed.
RevBio at a glance
Total raised
$45M
Latest round
Series A
Latest round date
June 2024
Industry
Biotech
Headquarters
Lowell, MA
Frequently asked about RevBio funding
How much has RevBio raised?
RevBio has raised $45M in total disclosed funding across the rounds on record.
Who has invested in RevBio?
No investors are named on the public record for RevBio yet.
What was the latest RevBio funding round?
The most recent disclosed round is a Series A, announced in June 2024.
Where is RevBio based?
RevBio is based in Lowell, MA.
What sector does RevBio operate in?
RevBio is tracked under Biotech from Lowell, MA, with $45M in disclosed funding.
When did RevBio last raise?
The last disclosed RevBio round closed in June 2024 at Series A.
Totals shown for RevBio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Lowell and the investors behind them below.
